PIEZO1 and esophageal squamous cell carcinoma: As this result was generated from only three ESCC patients' samples, we, then, investigated the PIEZO1 expression using both in‐house ESCC patients' samples and TCGA datasets, by which we found that PIEZO1 was significantly overexpressed in about 50% of ESCC patients.